细胞外囊泡在系统性硬化症肺纤维化传播中的作用
研究假设细胞外囊泡(EV)通讯驱动系统性硬化症(SSc)肺纤维化的传播,比较了SSc与正常人肺及原代肺成纤维细胞(pLF)来源的EV。结果显示SSc肺和pLF释放的EV显著更多、致纤维化内容与活性更强,TGFβ刺激可增加纤维化蛋白包装入EV,EV可在体外和体内诱导纤维化表型、与细胞外基质(ECM)相互作用,抑制EV释放可减轻小鼠肺纤维化。
要点
- SSc肺和pLF释放的EV显著多于正常肺,且致纤维化内容与活性增加。
- TGFβ刺激使纤维连接蛋白、胶原和TGFβ包装入释放的EV增多。
- EV可在体外和体内诱导纤维化表型,抑制EV释放可减轻小鼠肺纤维化。
核心结论
- EV通讯是SSc肺纤维化传播的新机制。
- 作者认为,确定减少SSc患者肺内EV释放、活性或致纤维化内容的疗法可能是改善纤维化的可行治疗策略。
研究设计与样本
- 从正常(NL)或SSc来源的人肺及原代肺成纤维细胞(pLF)中分离EV。
- 从人纤维化肺及经转化生长因子-β(TGFβ)实验性诱导的pLF中分离EV。
- 采用体外和体内功能试验评估EV的致纤维化能力。
- 使用透射电子显微镜、纳米颗粒跟踪分析、实时定量聚合酶链反应(RT-qPCR)、免疫印迹和免疫荧光分析EV、其内容物、细胞外基质(ECM)组分及条件培养基。
主要发现
- SSc肺和pLF释放的EV显著多于NL肺,其EV致纤维化内容与活性增加。
- TGFβ刺激的NL肺核心和pLF使纤维连接蛋白、胶原和TGFβ等纤维化蛋白包装入释放的EV增多。
- EV在受者pLF中及小鼠肺体内诱导纤维化表型。
- EV与ECM相互作用并参与ECM。
- 在体内抑制EV释放可减轻小鼠肺纤维化的严重程度。
临床怎么用
- 作者认为,确定减少SSc患者肺内EV释放、活性或致纤维化内容的疗法可能是改善纤维化的可行治疗策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Systemic sclerosis (SSc) has the highest mortality rate among the rheumatic diseases, with lung fibrosis leading as the cause of death. A characteristic of severe SSc-related lung fibrosis is its progressive nature. Although most research has focused on the pathology of the fibrosis, the mechanism mediating the fibrotic spread remains unclear. We hypothesized that extracellular vesicle (EV) communication drives the propagation of SSc lung fibrosis. METHODS: EVs were isolated from normal (NL) or SSc-derived human lungs and primary lung fibroblasts (pLFs). EVs were also isolated from human fibrotic lungs and pLFs induced experimentally with transforming growth factor-β (TGFβ). Fibrotic potency of EVs was assessed using functional assays in vitro and in vivo. Transmission electron microscopy, nanoparticle tracking analysis, real-time quantitative polymerase chain reaction (RT-qPCR), immunoblotting, and immunofluorescence were used to analyze EVs, their cargo, extracellular matrix (ECM) fractions, and conditioned media. RESULTS: SSc lungs and pLFs released significantly more EVs than NL lungs, and their EVs showed increased fibrotic content and activity. TGFβ-stimulated NL lung cores and pLFs increased packaging of fibrotic proteins, including fibronectin, collagens, and TGFβ, into released EVs. The EVs induced a fibrotic phenotype in recipient pLFs and in vivo in mouse lungs. Furthermore, EVs interacted with and contributed to the ECM. Finally, suppressing EV release in vivo reduced severity of murine lung fibrosis. CONCLUSIONS: Our findings highlight EV communication as a novel mechanism for propagation of SSc lung fibrosis. Identifying therapies that reduce EV release, activity, and/or fibrotic cargo in SSc patient lungs may be a viable therapeutic strategy to improve fibrosis.
引用
- Mouawad JE, Sanderson M, Sharma S, et al. Role of Extracellular Vesicles in the Propagation of Lung Fibrosis in Systemic Sclerosis. Arthritis Rheumatol. 2023. PMID: 37390364. doi:10.1002/art.42638
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。